Cargando…

Distinct Effector Memory CD4(+) T Cell Signatures in Latent Mycobacterium tuberculosis Infection, BCG Vaccination and Clinically Resolved Tuberculosis

Two billion people worldwide are estimated to be latently infected with Mycobacterium tuberculosis (Mtb) and are at risk for developing active tuberculosis since Mtb can reactivate to cause TB disease in immune-compromised hosts. Individuals with latent Mtb infection (LTBI) and BCG-vaccinated indivi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adekambi, Toidi, Ibegbu, Chris C., Kalokhe, Ameeta S., Yu, Tianwei, Ray, Susan M., Rengarajan, Jyothi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3335801/ https://www.ncbi.nlm.nih.gov/pubmed/22545156 http://dx.doi.org/10.1371/journal.pone.0036046

Ejemplares similares

High Frequencies of Caspase-3 Expressing Mycobacterium tuberculosis-Specific CD4(+) T Cells Are Associated With Active Tuberculosis
por: Adekambi, Toidi, et al.
Publicado: (2018)

Mycobacterium bolletii Respiratory Infections
por: Adékambi, Toïdi, et al.
Publicado: (2009)

Discordance in Mycobacterium tuberculosis Rifampin Susceptibility
por: Kalokhe, Ameeta S., et al.
Publicado: (2012)

Mucosal vaccination with attenuated Mycobacterium tuberculosis induces strong central memory responses and protects against tuberculosis
por: Kaushal, Deepak, et al.
Publicado: (2015)

Innate Immune Defenses in Human Tuberculosis: An Overview of the Interactions between Mycobacterium tuberculosis and Innate Immune Cells
por: Sia, Jonathan Kevin, et al.
Publicado: (2015)

In vivo inhibition of tryptophan catabolism reorganizes the tuberculoma and augments immune-mediated control of Mycobacterium tuberculosis
por: Gautam, Uma S., et al.
Publicado: (2018)

Mycobacterium setense Infection in Humans
por: Toro, Alexandre, et al.
Publicado: (2008)

Neutrophil extracellular trap (NET) levels in human plasma are associated with active TB
por: Schechter, Marcos C., et al.
Publicado: (2017)

Antiretroviral therapy timing impacts latent tuberculosis infection reactivation in a Mycobacterium tuberculosis/SIV coinfection model
por: Sharan, Riti, et al.
Publicado: (2022)

Advancing Adjuvants for Mycobacterium tuberculosis Therapeutics
por: Enriquez, Ana B., et al.
Publicado: (2021)

Anatomic and Cellular Niches for Mycobacterium tuberculosis in Latent Tuberculosis Infection
por: Mayito, Jonathan, et al.
Publicado: (2019)

Reactogenicity to major tuberculosis antigens absent in BCG is linked to improved protection against Mycobacterium tuberculosis
por: Aguilo, Nacho, et al.
Publicado: (2017)

Prevalence of latent Mycobacterium tuberculosis infection in prisoners
por: de Navarro, Pedro Daibert, et al.
Publicado: (2016)

An Overview of Genetic Information of Latent Mycobacterium tuberculosis
por: Hamidieh, Faezeh, et al.
Publicado: (2021)

Behçet’s disease with latent Mycobacterium tuberculosis infection
por: Shen, Yan, et al.
Publicado: (2020)

Maternal Latent Mycobacterium tuberculosis Does Not Affect the Infant Immune Response Following BCG at Birth: An Observational Longitudinal Study in Uganda
por: Lubyayi, Lawrence, et al.
Publicado: (2020)

Multiple small RNAs identified in Mycobacterium bovis BCG are also expressed in Mycobacterium tuberculosis and Mycobacterium smegmatis
por: DiChiara, Jeanne M., et al.
Publicado: (2010)

Engaging the CD40-CD40L pathway augments T-helper cell responses and improves control of Mycobacterium tuberculosis infection
por: Sia, Jonathan Kevin, et al.
Publicado: (2017)

Mycobacterium tuberculosis Secreted Proteins As Potential Biomarkers for the Diagnosis of Active Tuberculosis and Latent Tuberculosis Infection
por: Zhang, Caiqin, et al.
Publicado: (2014)

Immunogenicity and cross-reactivity against Mycobacterium tuberculosis of proteoliposomes derived from Mycobacterium bovis BCG
por: Reyes, Fátima, et al.
Publicado: (2013)

Diagnosis of latent tuberculosis infection in healthy young adults in a country with high tuberculosis burden and BCG vaccination at birth
por: Dagnew, Alemnew F, et al.
Publicado: (2012)

The blood transcriptional signature for active and latent tuberculosis
por: Deng, Min, et al.
Publicado: (2019)

Pathogenesis, Immunology, and Diagnosis of Latent Mycobacterium tuberculosis Infection
por: Ahmad, Suhail
Publicado: (2011)

BCG Induces Protection against Mycobacterium tuberculosis Infection in the Wistar Rat Model
por: Singhal, Amit, et al.
Publicado: (2011)

The Efficacy of the BCG Vaccine against Newly Emerging Clinical Strains of Mycobacterium tuberculosis
por: Henao-Tamayo, Marcela, et al.
Publicado: (2015)

Field evaluation of the efficacy of Mycobacterium bovis BCG vaccine against tuberculosis in goats
por: Vidal, Enric, et al.
Publicado: (2017)

Characterizing the BCG Induced Macrophage and Neutrophil Mechanisms for Defense Against Mycobacterium tuberculosis
por: Bickett, Thomas E., et al.
Publicado: (2020)

Monoclonal antibodies from humans with Mycobacterium tuberculosis exposure or latent infection recognize distinct arabinomannan epitopes
por: Ishida, Elise, et al.
Publicado: (2021)

Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries
por: Getahun, Haileyesus, et al.
Publicado: (2015)

SIV and Mycobacterium tuberculosis synergy within the granuloma accelerates the reactivation pattern of latent tuberculosis
por: Diedrich, Collin R., et al.
Publicado: (2020)

Preventive effects of Mycobacterium tuberculosis DNA vaccines on the mouse model with latent tuberculosis infection
por: Liang, Yan, et al.
Publicado: (2023)

BCG Vaccine: Tuberculosis—Cancer
por: Pimm, M. V.
Publicado: (1980)

BCG Vaccination and Tuberculosis in Japan
por: Rahman, Mahbubur, et al.
Publicado: (2007)

BCG Vaccination Prevents Reactivation of Latent Lymphatic Murine Tuberculosis Independently of CD4(+) T Cells
por: Sathkumara, Harindra D., et al.
Publicado: (2019)

Protective Effect of BCG and Neutrophil-to-Lymphocyte Ratio on Latent Tuberculosis in End Stage Renal Disease
por: Wang, Ping-Huai, et al.
Publicado: (2023)

Mycobacterium tuberculosis–derived circulating cell-free DNA in patients with pulmonary tuberculosis and persons with latent tuberculosis infection
por: Pan, Sheng-Wei, et al.
Publicado: (2021)

Implementation of trauma-informed care and trauma-responsive services in clinical settings: a latent class regression analysis
por: Anderson, Katherine M., et al.
Publicado: (2023)

Multiplexed Quantitation of Intraphagocyte Mycobacterium tuberculosis Secreted Protein Effectors
por: Sayes, Fadel, et al.
Publicado: (2018)

BCG-Vaccinated Children with Contact to Tuberculosis Patients Show Delayed Conversion of Mycobacterium tuberculosis-Specific IFN-γ Release
por: Owusu, Dorcas O., et al.
Publicado: (2023)

Identification of T-Cell Antigens Specific for Latent Mycobacterium Tuberculosis Infection
por: Schuck, Sebastian D., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_us7ptdmvi74f62tsn1j5s5g3dh